Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

STRATA Skin Sciences (SSKN) Other Non Operating Income (2016 - 2024)

Historic Other Non Operating Income for STRATA Skin Sciences (SSKN) over the last 9 years, with Q2 2024 value amounting to $864000.0.

  • STRATA Skin Sciences' Other Non Operating Income rose 19504.95% to $864000.0 in Q2 2024 from the same period last year, while for Jun 2025 it was $864000.0, marking a year-over-year increase of 202000.0%. This contributed to the annual value of $864000.0 for FY2024, which is 19504.95% up from last year.
  • Per STRATA Skin Sciences' latest filing, its Other Non Operating Income stood at $864000.0 for Q2 2024, which was up 19504.95% from -$909000.0 recorded in Q2 2023.
  • In the past 5 years, STRATA Skin Sciences' Other Non Operating Income ranged from a high of $2.0 million in Q2 2021 and a low of -$909000.0 during Q2 2023
  • Over the past 3 years, STRATA Skin Sciences' median Other Non Operating Income value was $432500.0 (recorded in 2021), while the average stood at $496000.0.
  • Data for STRATA Skin Sciences' Other Non Operating Income shows a peak YoY increase of 19504.95% (in 2024) and a maximum YoY decrease of 19504.95% (in 2024) over the last 5 years.
  • STRATA Skin Sciences' Other Non Operating Income (Quarter) stood at $1000.0 in 2021, then plummeted by 91000.0% to -$909000.0 in 2023, then skyrocketed by 195.05% to $864000.0 in 2024.
  • Its Other Non Operating Income was $864000.0 in Q2 2024, compared to -$909000.0 in Q2 2023 and $1000.0 in Q4 2021.